DOW JONES23,719.37+285.80 1.22%
S&P 5002,789.82+39.84 1.45%
NASDAQ8,153.58+62.67 0.77%

Menlo Therapeutics Q4 EPS $(0.89) Down From $(0.76) YoY

Menlo Therapeutics (NASDAQ:MNLO) reported quarterly losses of $(0.89) per share. This is a 17.11 percent decrease over losses of $(0.76) per share from the same period last year.

Benzinga · 03/03/2020 21:13

Menlo Therapeutics (NASDAQ:MNLO) reported quarterly losses of $(0.89) per share. This is a 17.11 percent decrease over losses of $(0.76) per share from the same period last year.